Subtype
Thyroid Gland Neoplasm
CI-CAN-00001600Explore in graph →
Non-malignant189 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001600Explore in graph →
Clinical trials
891 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04664413 | Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma(ABOUT) | unknown | — | 300 | University of SalernoOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT04666103 | Function Integrity of Neck Anatomy in Thyroid Surgery | recruiting | N/A | 1,264 | Wuhan UniversityOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) |
| unknown |
| — |
| 1,000 |
| SpeciCareINDUSTRY |
| 1 |
| Dec 4, 2020 |
| clinicaltrials |
| NCT02946918 | Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy | terminated | Phase 4 | 14 | University of Texas Southwestern Medical CenterOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT02412150 | Effect of Dexmedetomidine After Thyroidectomy | completed | N/A | 139 | Chosun University HospitalOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT03845647 | Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. | unknown | N/A | 50 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT03643055 | 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer | unknown | — | 80 | University Medical Centre LjubljanaOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04612894 | Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer | unknown | Phase 2 | 31 | Fudan UniversityOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT04594720 | Circulating Biomarkers to Identify Thyroid Cancer | completed | — | 100 | Chang Gung Memorial HospitalOTHER | 1 | Oct 20, 2020 | clinicaltrials |
| NCT02012231 | Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. | terminated | Phase 1 | 5 | Fore BiotherapeuticsINDUSTRY | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02709889 | Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 200 | AbbVieINDUSTRY | 1 | Oct 19, 2020 | clinicaltrials |
| NCT00341094 | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident | completed | — | 23,143 | National Cancer Institute (NCI)NIH | 1 | Oct 9, 2020 | clinicaltrials |
| NCT04574817 | Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) | unknown | Phase 2 | 66 | Taizhou Hanzhong biomedical co. LTDINDUSTRY | 1 | Oct 5, 2020 | clinicaltrials |
| NCT01441154 | Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment | completed | — | 16 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04560426 | Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation | unknown | N/A | 200 | Fudan UniversityOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT00603941 | A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel | terminated | Phase 1 / Phase 2 | 19 | Daiichi SankyoINDUSTRY | 1 | Sep 16, 2020 | clinicaltrials |
| NCT04106843 | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT04524884 | Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study | unknown | Phase 2 | 10 | Fudan UniversityOTHER | 1 | Aug 24, 2020 | clinicaltrials |
| NCT01728623 | A Study of E7080 in Subjects With Advanced Thyroid Cancer | completed | Phase 2 | 51 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 14, 2020 | clinicaltrials |
| NCT00668811 | Sutent Adjunctive Treatment of Differentiated Thyroid Cancer(IIT Sutent) | completed | Phase 2 | 23 | Medstar Health Research InstituteOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT04500925 | The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience | completed | — | 301 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Aug 5, 2020 | clinicaltrials |
| NCT01788982 | Nintedanib(BIBF1120) in Thyroid Cancer | completed | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 31, 2020 | clinicaltrials |
| NCT02174679 | 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) | no longer available | — | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT03294005 | Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography | completed | — | 1,949 | China Medical University HospitalOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT04076514 | The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma(pCND) | unknown | — | 20 | Assiut UniversityOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT02726503 | Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer(HOPE) | completed | Phase 2 | 39 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT03871387 | The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change | completed | N/A | 88 | Yonsei UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT00287287 | REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas | completed | Phase 2 | 25 | Kenneth AinOTHER | 1 | Jun 12, 2020 | clinicaltrials |
| NCT04424485 | Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy | unknown | N/A | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04425512 | Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy | completed | N/A | 333 | Kahramanmaras Sutcu Imam UniversityOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT04411290 | Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases | unknown | — | 200 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 2, 2020 | clinicaltrials |
| NCT04410601 | Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT(Dysphagia-TT) | unknown | N/A | 500 | Umraniye Education and Research HospitalOTHER_GOV | 1 | Jun 1, 2020 | clinicaltrials |
| NCT04396912 | Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort | unknown | — | 100 | Umraniye Education and Research HospitalOTHER_GOV | 1 | May 21, 2020 | clinicaltrials |
| NCT02223052 | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies | completed | Phase 1 | 89 | CelgeneINDUSTRY | 1 | May 12, 2020 | clinicaltrials |
| NCT02911155 | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | completed | — | 229 | National Cancer Institute (NCI)NIH | 1 | May 5, 2020 | clinicaltrials |
| NCT00784303 | Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology | completed | Phase 2 | 117 | Eisai Inc.INDUSTRY | 6 | Apr 22, 2020 | clinicaltrials |
| NCT00342407 | The Incidence of Breast and Other Cancers Among Female Flight Attendants | completed | — | 6,093 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2020 | clinicaltrials |
| NCT04336696 | Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? | unknown | N/A | 199 | Bassem Mohamed SiedaOTHER_GOV | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03969108 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Mar 27, 2020 | clinicaltrials |
| NCT03211117 | Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer | completed | Phase 2 | 3 | Mayo ClinicOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03246659 | Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC(GRAN-T-MTC) | completed | Phase 1 | 16 | Paola Anna ErbaOTHER | 5 | Mar 20, 2020 | clinicaltrials |
| NCT04312087 | Lateral Neck Lymph Node Mapping in Thyroid Cancer | unknown | N/A | 250 | Fudan UniversityOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT00339716 | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident | completed | — | 19,456 | National Cancer Institute (NCI)NIH | 1 | Mar 16, 2020 | clinicaltrials |
| NCT02658513 | Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | completed | — | 35 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT01265381 | Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study | terminated | — | 673 | National Cancer Institute (NCI)NIH | 1 | Mar 3, 2020 | clinicaltrials |
| NCT00625846 | Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer | completed | Phase 2 | 152 | National Cancer Institute (NCI)NIH | 5 | Feb 26, 2020 | clinicaltrials |
| NCT04274829 | Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid | completed | — | 300 | University of CagliariOTHER | 1 | Feb 18, 2020 | clinicaltrials |
| NCT02614495 | Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma | completed | Phase 2 | 66 | Hutchison Medipharma LimitedINDUSTRY | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04248166 | Thyroid Cancer and Photoacoustic Imaging | unknown | N/A | 100 | Seoul St. Mary's HospitalOTHER | 1 | Jan 30, 2020 | clinicaltrials |
| NCT03159585 | To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | completed | Phase 1 | 6 | Zhujiang HospitalOTHER | 1 | Jan 22, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Dec 14, 2020source: clinicaltrials